CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $16.93B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.2: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.38%Below 5Y avg (1.04%)
Annual Rate
INR 18.00Paid semi-annual
Payout Ratio
54.8%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.61TINR16.93B · vs all stocks (USD)
Trailing P/E
74.63xRevenue (TTM)
139.80BINR1.47B · vs all stocks (USD)
Profit Margin
15.47%Beta
0.1420xvs all stocks
52-Week Change
35.16%vs all stocks
Forward Annual Dividend Yield
0.38%vs all stocks
Market Capitalization
1.61TINR16.93B · vs all stocks (USD)
Enterprise Value
1.83TINR19.23B · vs all stocks (USD)
Trailing P/E
74.63xForward P/E
50.70xPrice to Sales (TTM)
11.53xPrice to Book (MRQ)
19.22xEnterprise to Revenue
13.10xEnterprise to EBITDA
40.71xGross Margin
75.41%Profit Margin
15.47%Operating Margin
20.20%Return on Assets (TTM)
7.25%Return on Equity (TTM)
16.99%Revenue (TTM)
139.80BINR1.47B · vs all stocks (USD)
Revenue per Share (TTM)
413.06INRUpdated Jul 20, 2026Quarterly Revenue Growth
41.80%Gross Profit (TTM)
105.92BINR1.11B · vs all stocks (USD)
EBITDA (TTM)
44.65BINR468.96M · vs all stocks (USD)
Net Income (TTM)
21.63BINR227.22M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.90%Operating Cash Flow (TTM)
30.23BINR317.48M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
26.01BINR273.21M · vs all stocks (USD)
Forward Annual Dividend Rate
18.00INRUpdated Jul 20, 2026Forward Annual Dividend Yield
0.38%vs all stocks
Trailing Annual Dividend Rate
38.00INRUpdated Jul 20, 2026Trailing Annual Dividend Yield
0.80%vs all stocks
5-Year Average Dividend Yield
1.04%vs all stocks
Payout Ratio
54.76%Minority Interest (Equity)
91.96BINRFY2026 · Mar 31, 2026Revenue
137.53BINRFY2026 · Mar 31, 2026Cost of Goods Sold
35.25BINRFY2026 · Mar 31, 2026Gross Profit
102.28BINRFY2026 · Mar 31, 2026Operating Income
34.40BINR361.28M · vs all stocks (USD)
Pre-tax Income
28.72BINRFY2026 · Mar 31, 2026Income Tax Expense
7.34BINRFY2026 · Mar 31, 2026Net Income
21.38BINRFY2026 · Mar 31, 2026EBIT
32.57BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
44.16BINRFY2026 · Mar 31, 2026Research & Development
449.50MINRFY2026 · Mar 31, 2026Selling, General & Administrative
23.92BINRFY2026 · Mar 31, 2026Other Operating Expenses
6.50BINRFY2026 · Mar 31, 2026Non-operating Interest Income
384.30MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
3.85BINRFY2026 · Mar 31, 2026Minority Interests (P&L)
251.90MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
27.12BINRFY2026 · Mar 31, 2026Free Cash Flow
20.76BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
11.17BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
28.72BINRFY2026 · Mar 31, 2026Other Non-cash Items
3.46BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-3.63BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-1.43BINRFY2026 · Mar 31, 2026Capital Expenditures
-6.36BINRFY2026 · Mar 31, 2026Net Acquisitions
-123.15BINRFY2026 · Mar 31, 2026Purchase of Investments
-127.90MINRFY2026 · Mar 31, 2026Sale of Investments
2.16BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-127.49BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
109.90BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-6.72BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
16.04BINRFY2026 · Mar 31, 2026Common Dividends Paid
-12.89BINRFY2026 · Mar 31, 2026Net Financing Cash Flow
106.33BINRFY2026 · Mar 31, 2026Shares Outstanding
338.45MSharesUpdated Jul 20, 2026Float Shares
103.99MSharesUpdated Jul 20, 2026% Held by Insiders
71.19%vs all stocks
% Held by Institutions
15.81%vs all stocks
Total Cash (MRQ)
23.55BINR247.37M · vs all stocks (USD)
Total Cash per Share (MRQ)
69.59INRUpdated Jul 20, 2026Total Debt (MRQ)
150.25BINR1.58B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8545xCurrent Ratio (MRQ)
1.13xBook Value per Share (MRQ)
247.85INRUpdated Jul 20, 2026Total Assets
443.12BINR4.65B · vs all stocks (USD)
Total Current Assets
93.92BINRFY2026 · Mar 31, 2026Total Liabilities
267.27BINRFY2026 · Mar 31, 2026Total Non-current Assets
349.20BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
183.84BINRFY2026 · Mar 31, 2026Total Current Liabilities
83.43BINRFY2026 · Mar 31, 2026Cash
4.42BINRFY2026 · Mar 31, 2026Cash Equivalents
6.75BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
11.17BINRFY2026 · Mar 31, 2026Other Short-term Investments
12.38BINRFY2026 · Mar 31, 2026Accounts Receivable
30.31BINRFY2026 · Mar 31, 2026Inventory
31.38BINRFY2026 · Mar 31, 2026Accounts Payable
23.58BINRFY2026 · Mar 31, 2026Short-term Debt
31.84BINRFY2026 · Mar 31, 2026Other Current Liabilities
1.00MINRFY2026 · Mar 31, 2026Long-term Debt
118.41BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
220.00MINRFY2026 · Mar 31, 2026Common Stock (Book)
1.69BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
175.85BINR1.85B · vs all stocks (USD)
52-Week Low
3.47KINRUpdated Jul 20, 202652-Week High
5.09KINRUpdated Jul 20, 202652-Week Change
35.16%vs all stocks
Beta
0.1420xvs all stocks
50-Day MA
4.56KINRUpdated Jul 20, 2026200-Day MA
4.13KINRUpdated Jul 20, 2026Avg 10-Day Volume
1.21MSharesUpdated Jul 20, 2026Avg 30-Day Volume
715.71KSharesUpdated Jul 20, 2026Diluted EPS (TTM)
63.82INRUpdated Jul 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Three-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Three years of positive free cash flow, with the 50-week average above the 200-week.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.2: safe zoneNotable
Altman Z-Score: 4.20
High earnings qualityNotable
Earnings Quality Score: 1.01
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $16.93B, above the global median of $1.15BNotable
Market cap (USD): 16,931,000,169.452Global Median: 1,146,734,693.424
Revenue is $1.47B, above the global median of $520.53MNotable
Revenue (USD): 1,468,291,033.498Global Median: 520,528,949.311
Levered free cash flow is $273.21M, above the global median of $16.24MNotable
Levered free cash flow (USD): 273,206,404.805Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Neurocrine Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sichuan Biokin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zimmer Biomet Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sonova Holding AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sino Biopharmaceutical Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BridgeBio Pharma, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ipsen S.A.
Tier 1ProductionApproval-Gated PipelineRule
Jazz Pharmaceuticals plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
ALTEOGEN Inc.
Tier 1ProductionApproval-Gated PipelineRule
Viatris Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Vijaya Diagnostic Centre Ltd.
3 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetMulti-Year Revenue, Profit, And Income GrowthThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Companhia de Saneamento de Minas Gerais
3 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetMulti-Year Revenue, Profit, And Income GrowthThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
DPM Metals Inc.
3 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetMulti-Year Revenue, Profit, And Income GrowthThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA